Yuimedi
PrivateLast Round
Series A
Feb 18, 2026
Total Funding Raised
$9.59M
Company Overview
Yuimedi is a health-tech company that provides an AI-powered medical data infrastructure platform for cleansing, standardizing, and analyzing clinical datasets.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Healthcare Analytics, Data Integration, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yuimedi Comparables
Compare Yuimedi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Datack, Inc. | 79% | |
| Life Data Initiative | 71% | |
| Roche Holding | 70% |
Yuimedi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 18, 2026 | ||||
| Early Funding | Jul 2, 2024 | ||||
| Early Funding | Nov 30, 2022 | ||||
| Accelerator | Nov 29, 2022 |
Key People
Founding team and executive leadership
Yuimedi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Darwin Venture Management | Series A |
| Sumitomo Mitsui Trust Bank | Series A |
| D4V (Design for Ventures) | Early Funding, Series A |
| Nissay Capital | Early Funding |
| DG Daiwa Ventures | Early Funding, Series A |
| Norinchukin Capital Co., Ltd. | Series A |
| Alchemist Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Monthly visitors grew 103% MoM, reaching 5.5K.
- Mar 4, 2026
Monthly visitors increased 43% MoM.
Yuimedi Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Yuimedi's valuation, stock price, and market status.
Is Yuimedi a public or private company?
Yuimedi is a private company.
What is the current stock price of Yuimedi?
Yuimedi is a private company with no public stock price. No recent secondary market data is available.
How much is Yuimedi worth (valuation)?
Valuation information for Yuimedi is not publicly available.
Can I buy Yuimedi stock?
Yuimedi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Yuimedi's last funding round?
Yuimedi's most recent funding round was Series A on February 18, 2026.
Who are the main investors in Yuimedi?
Key investors in Yuimedi include DG Daiwa Ventures, Chiba Dojo Fund.
Will Yuimedi IPO soon?
No public IPO plans have been announced for Yuimedi.
How can I track Yuimedi secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yuimedi's secondary market activity and sign up for updates.